• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Boston Scientific reworks retention pacts

Boston Scientific reworks retention pacts

March 4, 2010 By MassDevice staff

Boston Scientific Corp. (NYSE:BSX) still wants to make it expensive for a buyer to clean house following an acquisition — although in the future it won’t be quite as costly as it once was.

In mid-December, the Natick, Mass.-based device conglomerate revamped its executive retention agreements, triggered by a change in control of the company. The new contracts eliminate some of tax benefits the company previously paid for its executives if the firm is sold. It also somewhat modified the definition of “good cause” executives can cite prior to leaving Boston Scientific with exit compensation packages intact.

Like most companies of its size, senior managers at Boston Scientific would be well compensated if they are let go, or walk away, following its acquisition by another firm. Under terms of the revised agreements, they are now entitled to three times the sum of their regular salary, plus any performance or yearly cash bonuses they’re entitled to, along with an extra $25,000. All outstanding stock options and restricted stock awards also vest immediately.

Still, because the new terms could be considered less favorable for the affected executives than their previous pacts, the Boston Scientific board decided to offer them an one-time award of $15,000 in stock options as an enticement to sign the new retention agreements. The option grants were disclosed in securities filings this week and will vest in four equal annual installments starting Feb. 26, 2011.

To date, all but one of the company’s c-level officers — including CEO Raymond Elliott and Chief Financial Officer Sam Leno — along with seven of the 11 division heads on the Boston Scientific executive committee have signed the new retention agreements.

Filed Under: Business/Financial News, News Well Tagged With: Boston Scientific

More recent news

  • Aurora Spine begins first procedures with Aero lumbar fusion system
  • Caranx Medical surgical robot TaviPilot AI software wins FDA clearance
  • InspireMD launches carotid stent in U.S. after FDA approval
  • Neuros Medical raises $56M Series D to support nerve stim tech
  • CorWave reports first-in-human LVAD implant

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy